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S U M M A R Y
Objectives: This study was performed to evaluate the epidemiological status of cutaneous leishmaniasis
(CL) in the most important endemic foci of Qom Province, central Iran. The city of Qom is the largest
center for Shi’a scholarship in the world and is a signiﬁcant pilgrimage destination.
Methods: During 2006–2011, all suspected CL patients with skin lesion(s) referred to regional health
centers of Ghomrood and Ghanavat regions, and all actively detected cases, were examined clinically and
parasitologically for CL. Patient information was recorded and patients were categorized based on the
number and size of the lesions. Odds ratios (OR) of different risk factors were calculated.
Results: A total of 849 (59.2% male, 40.8% female) conﬁrmed cases of CL were enrolled; the average
incidence rate of the disease was 14.9 per 100 000 people. During the study period 2006–2011, the trend
in CL incidence showed no sudden variations in the areas studied, except for an outbreak of CL in 2009.
Leishmania major was identiﬁed as the causative agent based on internal transcribed spacer 1 (ITS1)
ribosomal DNA PCR analysis. During the study period, the age distribution of CL cases was relatively
stable, with the majority (50%) of patients aged 1–25 years. Most cases (n = 468; 55.1%) had a single
lesion and 82 (9.6%) patients had four or more lesions (range 1–29). The risk of developing multiple
lesions was signiﬁcantly increased in patients with seasonal jobs (summer workers) (p = 0.023; OR
1.516) and signiﬁcantly decreased in patients who were affected in winter (p = 0.010; OR 0.398). The risk
of developing large-sized lesions (>1 cm) was signiﬁcantly increased in patients in the age groups >25
years (p = 0.001–0.015; OR 2.5–3.5) and decreased in patients with seasonal jobs (summer workers) (p =
0.005; OR 0.570).
Conclusions: The present data show the importance of CL as a health problem in suburban areas of Qom
Province. In order to identify other epidemiological aspects of leishmaniasis in this area, studies on
vectors and reservoirs are recommended. Since leishmaniasis caused by L. major is typically zoonotic,
control measures should focus on rodents as the main reservoirs and Phlebotomus papatasi as the main
vector. Awareness should be raised in the high-risk populations comprising people with diabetes, young
adults (<25 years old), and those who work outdoors during the summer.
 2013 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Leishmaniasis is a protozoan parasitic disease caused by
Leishmania species. It is estimated that in about 100 countries,
approximately 350 million people are at risk of acquiring
leishmaniasis and 12 million are infected; an estimated two
million new cases occur annually.1 The two most common clinical
forms of the disease, cutaneous leishmaniasis (CL) and visceral
leishmaniasis (VL), are mainly seen in 14 of the 22 countries of
the World Health Organization (WHO) Eastern Mediterranean* Corresponding author. Tel.: +98 21 88970657; fax: +98 21 88963804.
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zoonotic CL (ZCL) due to Leishmania major and anthroponotic CL
(ACL) due to Leishmania tropica are two known types of CL that are
spread across most parts of Iran. In total, approximately 17 out of
the 31 provinces of Iran are endemic foci for ZCL.3 According to the
ofﬁcial reports of the Ministry of Health, the average incidence rate
of CL is usually between 20 and 40 cases per 100 000 population.4
The endemic regions in the central and south-western parts of the
country (including Yazd, Semnan, Fars, Ilam, Khoozestan, and
Isfahan), with an average incidence of more than 150/100 000
population, have the highest rates of CL.4 The number of reported
CL cases increased from 13 729 in 2002 to more than 24 000 in
2006 and thereafter,4 and the disease prevalence is increasing and
new foci of CL are emerging in Iran.5–7ses. Published by Elsevier Ltd. All rights reserved.
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southwest of the capital Tehran, and is the passageway to more
than 17 provinces. Each year more than 14 million people travel to
or pass through this province; about two million of them are
pilgrims who may stay for a while in the city.8 The city of Qom is
currently the largest city for Shi’a scholarship in the world.9 It is
estimated that 10–20% of the total world Muslim population, and
more than 38% of the local Muslim population of the Middle East,
are Shi’a.10 Shi’a Muslims consider Imam Ali as the rightful
successor to Prophet Muhammad, and the ﬁrst divinely appointed
Imam.10 There are an estimated 50 000 seminarians in Qom
coming from more than 70 countries of Africa, Asia, the Middle
East, and other parts of the world.9 Thousands of immigrants from
neighboring countries including Afghanistan and Iraq travel to Iran
intermittently and also play a role in importing leishmaniasis to
Qom. This huge number of travelers and immigrants make
leishmaniasis a priority in health strategy planning for the
province.
The most important foci of CL in Qom Province are the villages
of Ghomrood and Ghanavat regions, and the ﬁrst cases of CL were
diagnosed in 1999 in an outbreak of leishmaniasis in Ghanavat
region.11 Based on observations, CL cases have constantly been
referred from the province to regional health centers during recent
years. However, there is no formal report on the endemicity of CL in
suburban areas of Qom Province. Since ACL and ZCL have different
features with respect to ecology, parasitology, entomology, and
clinical characteristics,12 epidemiological data are needed to
establish effective control strategies in the region. This information
could help in the integration of the surveillance of leishmaniasis
into health system programs, monitoring of leishmaniasis trends
during outbreaks, risk assessment for awareness of decision-
makers and education of high-risk populations, investigation of
ﬂuctuations in vectors/reservoirs, and improving treatment
strategies. This study reports the epidemic aspects of CL in Qom
Province during recent years.
2. Materials and methods
2.1. The region
Qom is one of the 31 provinces of Iran and is situated between
508 060–518 580 E and 348 090–358 110 N, with an area of 11 237 km2,
covering 0.89% of the total land of the country. Qom Province is
located in the central part of the country; it lies 120 km by road
southwest of the capital Tehran and has one city, ﬁve counties, nine
rural districts, and 256 villages8 (Figure 1). Based on the most
recent census of 2011, the province has a population of
approximately 1 200 000, with 95.1% residing in urban areas
and 4.9% in rural areas.13 The climate of Qom Province varies from
semi-desert to desert conditions; the annual rainfall in the last year
was 86.9 mm and relative humidity ranged between 8.5% in June
and 89.1% in December. Geographically, the province comprises
mountainous areas, foothills, and plains, and in the last year, the
minimum and maximum temperatures recorded were 14 8C in
December and +47 8C in June.8
2.2. Population and sampling
This study was done during April 2006 to November 2011. All
suspected CL patients with skin lesion(s) referred to regional
health centers of the province were examined clinically and
parasitologically for CL. In addition to this passive case detection,
monthly routine house-to-house investigations in Markazi District
(including Ghanavat and Ghomrood regions) for active detection of
possible CL cases was done by trained staff during an outbreak in
2009. Furthermore, from 2006, in accordance with a Ministry ofHealth instruction, patients under treatment were actively
followed up and visited in their homes to ensure treatment
courses were fulﬁlled; possible side effects were recorded and
other members of the family were checked for the onset of lesions.
The population of the region is among the low income populations;
patients would not be able to attend private clinics for CL, and even
if they did, they would have to be referred to a health center for
treatment services since Glucantime is only distributed in these
health centers. Ghanavat and Ghomrood each has one health
center. Leishmaniasis is included in the surveillance system, and
the staff of these centers are informed of leishmaniasis, so we
assume that every case of cutaneous leishmaniasis in the region
should be diagnosed.
Patient information including demographic data and clinical
history was recorded on speciﬁc forms. Using the average
number of new cases that occurred each year during the study
period as the numerator and the population at risk as the
denominator, the average annual incidence rate of the disease
was calculated. The size and the number of lesions were recorded
at the time of diagnosis. For each lesion, two crossing diameters
were measured using a metric caliper and the mean ﬁgure was
recorded as the size of the lesion. If multiple lesions were
present, all lesions were measured and a mean size was
calculated and presented.
The skin was sterilized and exudates from the margins of the
suspected lesions were taken, ﬁxed with methanol, and stained
with Giemsa, then examined under a microscope. Part of the lesion
exudate was inoculated into Novy–MacNeal–Nicolle (NNN)
medium overlaid with RPMI 1640 (Gibco Invitrogen, Carlsbad,
CA, USA). This was incubated at 24 8C for 1 week and examined
every day for parasite growth. Another sample was taken and
transferred to 2-ml vials containing sterile phosphate buffered
saline (PBS) and used for DNA extraction. The disease was
diagnosed based on the clinical examination and microscopic
observation of intracellular amastigotes in smear or promastigotes
in NNN medium.
The most frequent type of treatment was local intra-lesional
administration of meglumine antimoniate (Glucantime) followed
by systemic Glucantime. The treatment responses and possible
side effects in the patients who received standard therapy were
recorded. Patients were categorized based on (1) the number of
lesions: single lesion or multiple lesions, and (2) the size of lesions:
small-sized lesion (<1 cm) and large-sized lesion (>1 cm). Odds
ratios (OR) of different variables as risk factors in the outcome of
disease were analyzed.
2.3. Molecular identiﬁcation of parasites by PCR
2.3.1. DNA extraction
Parasite genomic DNA was extracted using the conventional
phenol–chloroform procedure.14 Brieﬂy, 100 ml of each disrupted
tissue sample was transferred to a 1.5-ml microtube containing
200 ml of lysis buffer (100 mM Tris–HCl, pH 8; 10 mM ethylene-
diaminetetraacetic acid (EDTA), pH 8; 1% sodium dodecyl sulfate
(SDS); 100 mM NaCl; 2% Triton X-100) (Sigma, St. Louis, MO, USA)
with 20 ml proteinase K (100 mg/ml), vortexed, and incubated at
56 8C for 1 h. Three hundred microliters of phenol–chloroform
(1:1) was added, vortexed, and centrifuged at 5000 rpm, 4 8C, for
5 min. The supernatant was transferred to a new microtube and
chloroform extraction was performed again. An equal volume of
isopropanol and 1/10 volume of 3 M sodium acetate (pH 5.2) was
added to the supernatant, incubated at 70 8C for 15 min, and
centrifuged at 12 000 rpm for 15 min; the precipitant was then
washed with 70% ethanol by centrifugation at 12 000 rpm for
10 min. The pellet was air-dried and resuspended in 20 ml of
distilled water and stored at 20 8C until use.
Figure 1. Geographic location of Qom Province and its districts, showing the regions of study. Hatched areas show lakes. Markazi District (including Ghomrood and Ghanavat)
is highlighted.
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Identiﬁcation of the causative agent of the disease was
performed using internal transcribed spacer 1 (ITS1) ribosomal
DNA PCR. The Leishmania-speciﬁc target gene was ampliﬁed using
primers Leish-F (50-CCT CTC TTT TTT CNC TGT GC-30) and Leish-R
(50-CAA CAC GCC GCC TCC TCT CT-30), yielding a 600-bp fragment
for L. major and an 800-bp fragment for L. tropica. Ampliﬁcation of
the target genes was carried out in a total volume of 25 ml
containing 2 ml 10 PCR buffer, 1.5 mM MgCl2, 0.5 ml of each
primer (25 pmol/ml), 0.2 mM of each dNTPs, and 0.5 U Taq DNA
polymerase (Fermentas Life Sciences, York, UK). The cycling
program was initiated by early denaturation of 5 min at 95 8C,
followed by 35 cycles of 94 8C for 30 s, 60 8C for 45 s, and 72 8C for
60 s, then by a ﬁnal extension step at 72 8C for 5 min. PCR products
were electrophoresed on 1% agarose gel and visualized under a UV
transilluminator.
2.4. Data analysis
Data processing and the statistical analysis were performed
using SPSS v. 18 (SPSS Inc., Chicago, IL, USA) and GraphPad Prism v.
5.01 (GraphPad Software Inc., La Jolla, CA, USA) software. Pearson
Chi-square, Fisher’s exact, and univariate logistic regression
analyses were used for the different comparisons. p-Values of
0.05 were considered signiﬁcant.
3. Results
Clinically and parasitologically proven cases of CL were
recorded from the villages of Ghomrood and Ghanavat regions.
Patient data are given in Tables 1 and 2. A total 849 cases of CL
(59.2% male, 40.8% female) were enrolled during the study period,
from 2006 to 2011; 417 (49.1%) were residents of Ghanavat and
432 (50.9%) were recorded from Ghomrood region (Figure 2).
During the study period, among the patients with skin lesions, only
one case was diagnosed as having lupus erythematosus. In the
areas under study, the maximum number of cases was recorded in
2009 with 312 cases (36.7% of total) and the least number of caseswas recorded in 2008 with 34 cases (4% of total). With an average
138 new cases occurring each year during 2006–2011, and a
population at risk estimated to be 954 000, the average annual
incidence rate of the disease in Markazi District (including
Ghomrood and Ghanavat) was calculated to be approximately
14.9 per 100 000 people.
Most of the CL patients were Iranian (88.2%), and 19.6% of the
patients had traveled to a known endemic area during the last year.
The mean  standard deviation (SD) age of the patients was
29.5  19.44 years, and most of the patients were assigned to the
1–15 and 16–25 years age groups, with approximately 25% of the
total recorded CL cases for each group.
Based on PCR analysis, the parasites isolated from the lesions
were characterized as L. major. The mean  SD size of CL lesions was
1.41  0.74 cm. While most of the patients (55.1%) had only one skin
lesion, about 9.6% of the cases developed more than four lesions. The
number of lesions per patient ranged from 1 to 29, with the hand and
foot the most common sites of lesion onset (78.7% of total) (Figure 3).
Seventeen percent of the patients were suffering from a chronic non-
communicable disease such as diabetes, and housekeepers suffered
more from CL than those in other occupation groups.
Eight hundred and thirty-one out of 849 patients responded to
Glucantime (intra-lesional/systemic) alone or in combination with
cryotherapy. In total, about 97.8% of the patients responded to
Glucantime alone or in combination. Glucantime was well
tolerated and only a few patients showed mild signs such as
nausea, vomiting, malaise, and local inﬂammation. No serious side
effects were recorded, but the treatment was interrupted in three
patients because of impaired renal function.
Pearson Chi-square analysis showed a signiﬁcant difference
between the patients with single lesions and those with multiple
lesions with regard to seasonal jobs (summer workers) (p = 0.016).
The age group 1–15 years (p = 0.018) and the season of onset of
winter (p = 0.015) were signiﬁcantly different between patients
with single lesions and those with multiple lesions. Univariate
logistic regression analysis showed that the risk of developing
multiple lesions was increased 1.5-fold in patients with seasonal
jobs (summer workers) (Table 1) (p = 0.023; OR 1.516; 95%
Table 1
Results of regression analysis in cutaneous leishmaniasis (CL) groups categorized based on the presence of single or multiple lesions
Characteristics CL groups: number of patients (%) p-Value OR 95% CI
Single lesion Multiple lesions Total
Gender
Femalea 204 (43.6%) 142 (37.3%) 346 (40.8%) - - -
Male 264 (56.4%) 239 (62.7%) 503 (59.2%) 0.063 1.301 0.986–1.715
Nationality
Iraniana 417 (89.1%) 332 (87.1%) 749 (88.2%) - - -
Afghan 51 (10.9%) 49 (12.9%) 100 (11.8%) 0.378 0.829 0.546–1.258
Job
Housekeepera 141 (30.1%) 102 (26.8%) 243 (28.6%) - - -
Farmer 61 (13.0%) 50 (13.1%) 111 (13.1%) 0.588 1.133 0.721–1.781
Rancher 75 (16.0%) 65 (17.1%) 140 (16.5%) 0.398 1.198 0.788–1.821
Student 77 (16.5%) 39 (10.2%) 116 (13.7%) 0.130 0.700 0.441–1.111
Seasonal worker 114 (24.4%) 125 (32.8%) 239 (28.2%) 0.023 1.516 1.058–2.172
Travel history
Noa 380 (81.2%) 303 (79.5%) 683 (80.4%) - - -
Yes 88 (18.8%) 78 (20.5%) 166 (19.6%) 0.542 1.112 0.791–1.562
History of diabetes
Noa 394 (84.2%) 307 (80.6%) 701 (82.6%) - - -
Yes 74 (15.8%) 74 (19.4%) 148 (17.4%) 0.168 1.283 0.900–1.830
Season of onset
Springa 32 (6.8%) 31 (8.1%) 63 (7.4%) - - -
Summer 78 (16.7%) 66 (17.3%) 144 (17.0%) 0.655 0.873 0.483–1.580
Autumn 301 (64.3%) 262 (68.8%) 563 (66.3%) 0.687 0.899 0.534–1.513
Winter 57 (12.2%) 22 (5.8%) 79 (9.3%) 0.010 0.398 0.198–0.800
Area
Ghanavata 247 (52.8%) 185 (48.6%) 432 (50.9%) - - -
Ghomrood 221 (47.2%) 196 (51.4%) 417 (49.1%) 0.221 0.845 0.644–1.107
Age, years
1–15a 129 (27.6%) 83 (21.8%) 212 (25.0%) - - -
16–25 107 (22.9%) 106 (27.8%) 213 (25.1%) 0.691 1.118 0.643–1.944
26–35 87 (18.6%) 70 (18.4%) 157 (18.5%) 0.744 0.908 0.510–1.617
36–45 63 (13.5%) 33 (8.7%) 96 (11.3%) 0.108 0.591 0.311–1.123
46–55 37 (7.9%) 37 (9.7%) 74 (8.7%) 0.720 1.129 0.581–2.194
56 45 (9.6%) 52 (13.6%) 97 (11.4%) 0.406 1.305 0.697–2.442
Type of treatment
Local Glucantime 378 (80.8%) 172 (45.1%) 450 (53.0%)
Systemic Glucantime 31 (6.6%) 160 (42.0%) 291 (34.3%)
Local + cryotherapy 51 (10.9%) 46 (12.1%) 97 (11.4%)
Cryotherapy 8 (1.7%) 3 (0.8%) 11 (1.3%)
Lesion location
Multiple locations on the bodya 29 (6.2%) 60 (15.7%) 89 (10.5%) - - -
Hand or foot 383 (81.8%) 285 (74.8%) 668 (78.7%) 0.071 1.360 0.925–1.575
Face 56 (12.0%) 36 (9.5%) 92 (10.8%) 0.060 1.311 0.969–1.572
Total 468 (55.1%) 381 (44.9%) 849 (100%)
OR, odds ratio; CI, conﬁdence interval.
a Reference group.
M. Nateghi Rostami et al. / International Journal of Infectious Diseases 17 (2013) e1198–e1206 e1201conﬁdence interval (CI) 1.058–2.172). The risk of developing
multiple lesions was decreased in patients who were affected in
winter (p = 0.010; OR 0.398; 95% CI 0.198–0.800).
Regarding the lesion size, Pearson Chi-square analysis showed a
signiﬁcant difference between patients with small-sized lesions
and those with large-sized lesions concerning seasonal jobs
(summer workers) (p = 0.029), a history of diabetes (p = 0.021),
and the age group 1–25 years (p = 0.014). Univariate logistic
regression analysis showed that the risk of developing large-sized
lesions was increased 1.56-fold in patients with a history of
diabetes (Table 2) (p = 0.017; OR 1.562; 95% CI 1.084–2.251). Using
backward-Wald analysis, chronic diseases remained an indepen-
dent risk factor for the development of large-sized lesions (p =
0.018; OR 1.556; 95% CI 1.079–2.243). The risk of developing large-
sized lesions was decreased in patients with seasonal jobs
(summer workers) (p = 0.005; OR 0.570; 95% CI 0.385–0.843).
The likelihood of developing large-sized lesions was increased 2.5–
3.5-fold in patients aged 26 years.
4. Discussion
Qom Province is among the high risk regions for acquiring CL
due to its proximity to other CL endemic foci such as Isfahan,Kashan, and Semnan at the center of Iran. The special religious
status of Qom, with high numbers of pilgrims and immigrants,
gives it a crucial role in the prevalence of leishmaniasis. Every
year, many cases of CL are reported from Markazi District,
including Ghomrood and Ghanavat. Detailed data of the
geographical distribution of CL cases among the villages and
possible reservoirs of disease are under review for publication: the
same authors found that in Ghomrood region, among 104 villages,
most of the cases were from Kooh-seﬁd with 27.8% of all
conﬁrmed cases, and in Ghanavat region, among 27 villages,
most of the cases were from Ghanavat center with 23.5% of all
conﬁrmed cases during 2006–2011. Some rodents were identiﬁed
as the possible vectors.
The average incidence rate of the disease in the region is close to
the average incidence rate of 20–40 per 100 000 people estimated
for the country.5 Looking at neighboring provinces, a study of the
prevalence of CL in 117 children in three areas in the southeast of
Kashan, showed a prevalence of 7.2%.15 The prevalence of CL in
Orzoieh District, Kerman Province was found to be 4.7%,16 and in
3024 individuals of three villages around Ardakan, Yazd Province,
was found to be 30.4% and 24.6% for scars and ulcers, respectively.6
In the city of Yazd, examination of 3176 primary school children
showed a rate of 0.7% for scars and 0.2% for active lesions of ACL,
Table 2
Results of regression analysis in cutaneous leishmaniasis (CL) groups categorized based on lesion size
Characteristics CL groups: number of patients (%) p-Value OR 95% CI
Lesion size 1 cm Lesion size >1 cm Total
Gender
Femalea 230 (39.9%) 116 (42.5%) 346 (40.8%) - - -
Male 346 (60.1%) 157 (57.5%) 503 (59.3%) 0.478 0.9 0.672–1.205
Nationality
Iraniana 516 (89.6%) 233 (85.3%) 749 (88.2%) - - -
Afghan 60 (10.4%) 40 (14.7%) 100 (11.8%) 0.075 1.476 0.961–2.267
Job
Housekeepera 153 (26.6%) 90 (33.0%) 243 (28.6%) - - -
Farmer 68 (11.8%) 43 (15.7%) 111 (13.1%) 0.759 1.075 0.677–1.707
Rancher 94 (16.3%) 46 (16.8%) 140 (16.5%) 0.411 0.832 0.537–1.290
Student 82 (14.2%) 34 (12.5%) 116 (13.7%) 0.151 0.705 0.437–1.136
Seasonal worker 179 (31.1%) 60 (22.0%) 239 (28.2%) 0.005 0.570 0.385–0.843
Travel history
Noa 465 (80.7%) 218 (79.8%) 683 (80.4%) - - -
Yes 111 (19.3%) 55 (20.2%) 166 (19.6%) 0.764 1.057 0.737–1.516
History of diabetes
Noa 488 (84.7%) 213 (78.0%) 701 (82.6%) - - -
Yes 88 (15.3%) 60 (22.0%) 148 (17.4%) 0.017 1.562 1.084–2.251
Season of onset
Springa 42 (7.3%) 21 (7.7%) 63 (7.4%) - - -
Summer 97 (16.8%) 47 (17.2%) 144 (17.0%) 0.922 0.969 0.517–1.818
Autumn 381 (66.2%) 182 (66.7%) 563 (66.3%) 0.871 0.955 0.550–1.661
Winter 56 (9.7%) 23 (8.4%) 79 (9.3%) 0.589 0.821 0.402–1.678
Area
Ghanavata 286 (49.7%) 131 (48.0%) 417 (49.1%) - - -
Ghomrood 290 (50.3%) 142 (52.0%) 432 (50.9%) 0.650 1.069 0.801–1.426
Age, years
1–15a 155 (26.9%) 57 (20.9%) 212 (25.0%) - - -
16–25 154 (26.7%) 59 (21.6%) 213 (25.1%) 0.074 1.916 0.938–3.910
26–35 105 (18.2%) 52 (19.0%) 157 (18.5%) 0.015 2.476 1.196–5.126
36–45 56 (9.7%) 40 (14.7%) 96 (11.3%) 0.001 3.571 1.664–7.667
46–55 45 (7.8%) 29 (10.6%) 74 (8.7%) 0.004 3.222 1.451–7.157
56 61 (10.6%) 36 (13.2%) 97 (11.4%) 0.006 2.951 1.370–6.356
Type of treatment
Local Glucantime 320 (55.6%) 130 (47.6%) 450 (53.0%)
Systemic Glucantime 190 (33.0%) 101 (37.0%) 291 (34.3%)
Local + cryotherapy 61 (10.5%) 36 (13.2%) 97 (11.4%)
Cryotherapy 5 (0.9%) 6 (2.2%) 11 (1.3%)
Lesion location
Multiple locations on the bodya 62 (10.8%) 27 (9.9%) 89 (10.5%) - - -
Hand or foot 451 (78.3%) 217 (79.5%) 668 (78.7%) 0.684 1.105 0.684–1.786
Face 63 (10.9%) 29 (10.6%) 92 (10.8%) 0.863 1.057 0.563–1.986
Total 576 (67.8%) 273 (32.2%) 849 (100%)
OR, odds ratio; CI, conﬁdence interval.
a Reference group.
Figure 2. Age distribution of conﬁrmed CL cases in Qom Province identiﬁed during
2006–2011. Filled symbols represent male patients; open symbols represent female
patients. Mean (horizontal line) with SD (whiskers) for each group are shown.
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for ulcers.17
Both ACL and ZCL are reported from countries neighboring Iran,
including Afghanistan, Pakistan, Iraq, Saudi Arabia, and Turkey.18–
25 In the southeastern and Mediterranean regions of Turkey,
hundreds of CL cases due to L. tropica are reported each year.18 ZCL
caused by L. major is a growing public health problem and is
endemic in many parts of Saudi Arabia.19 Both ACL and ZCL are
major public health problems in all four provinces of Pakistan20
and are widespread in Afghanistan.21–24 In Afghanistan, the
majority of leishmaniasis cases are caused by L. tropica.21 WHO
estimates more than 200 000 ACL cases in Kabul which is the most
important endemic region of ACL in the world.22 ZCL due to L. major
is common in rural areas of north and north-west Afghanistan, as
in Mazar-e Sharif and Balkh.23,24 In the present population, a few
cases of leishmaniasis were imported into the regions by people
who had traveled to Afghanistan before the lesions appeared.
Afghans might have a role in parasite maintenance and disease
transmission in the area. However, a signiﬁcant number of cases
were Iranian with no history of travel to regions endemic for CL, so
local transmission is occurring in these areas. Isfahan Province,
Figure 3. Representative pictures of skin lesions observed in cutaneous leishmaniasis patients. (A) single lesion; (B) multiple lesions; (C) and (D) multiple lesions with
sporotrichoid extension along lymphatic vessels; (E) small-sized lesion (1 cm) before and after treatment; (F) large-sized lesions (>1 cm) before and after treatment.
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neighboring province of Qom, and transmission of infection from
Isfahan to Qom is possible. During the study period of 2006–2011,
the trend in CL incidence showed no sudden variations in the areas
under study, except for an outbreak in 2009. While changes in the
incidence of CL hardly exceeded 20% of the mean rate during 2006–
2008, in 2009 an outbreak of leishmaniasis occurred in the regions,
in which the number of CL cases increased to more than 10 times
and then decreased steadily to previous levels. Since surveillance
strategies and diagnostic procedures were not changed or
improved in that year, this increase in the report of conﬁrmed
CL cases was most likely due, not to better detection, but to a
greater occurrence of disease. Possible explanations for this
outbreak might be: the spread of disease from neighboring
provinces like Isfahan, importing new cases through immigrants,
changes in climate favoring an increase in vector/reservoir
populations, etc.
Of the total 849 patients, the male/female ratio was >1 and the
frequency of male patients with CL was higher than that of female
patients. Other endemic regions of the country have the same
pattern, such as Damghan26 and Kashan.15 Conversely, in Kerman
Province, CL was found to be distributed more signiﬁcantly in
females (5.2%) than males (4.3%).16 Some studies have shown an
equal distribution of ZCL infection among the two sexes. In Baft27
and in villages of Ardakan,6 the sex distribution was found to be
approximately equal. In the ACL-endemic city of Kabul,
Afghanistan, a house-to-house investigation showed that females
were at signiﬁcantly higher risk of developing leishmaniasis
lesions or scars than males.28
The transmission of leishmaniasis is highly dependent on
climate conditions and on the ecology of vector/reservoir hosts.12
Each species of sand ﬂy has an annual cycle, and the highest
transmission occurs at the end of this cycle.29 The seasonal
distribution of the disease shows that the highest rate of infection
is in the autumn and the lowest in the spring and winter. The lower
incidence of CL in winter was found to coincide with the lower risk
of developing multiple lesions (OR 0.398). In this area, the period
during which Phlebotomus sand ﬂies are most active begins in the
second month of spring (April) and lasts through the second month
of autumn (November).29 In ZCL, the average incubation period
from mosquito bite to nodule development in the skin is around 6
months. Taking into consideration the peak period of sand ﬂy
activity and the incubation period for lesion development, an
increase in CL cases is expected in the autumn. A similar seasonal
pattern has been reported from other leishmaniasis endemic parts
of the country. In Sabzevar (73.1%), Damghan (76.3%), and
Kermanshah, the highest percentages of patients with ZCL were
reported in autumn and the lowest in winter.26,30–32 Faulde et al.
described the seasonality of ZCL in Mazar-e Sharif, Afghanistan,
where the maximum numbers of CL cases were recorded in
September and October.23 Conversely, in Iraq, in a survey among
107 CL cases presenting to the dermatology clinic of a general
hospital in Alhaweja,25 the highest number was recorded in
February (32.1%) and the lowest number in April (3.37%). Weather
conditions directly inﬂuence the ﬂuctuation and breeding of sand
ﬂies12 and the warm climate of Iraq should be considered when
interpreting this discrepancy in seasonality of ZCL.
Most of the affected patients in the current study comprised
housewives. It should be considered that normally all house-
keepers are women, so the men were divided into other
occupations. In reports from Damghan and Kalaleh, most of the
CL patients were housewives.31,33 In contrast, in Hamadan
Province 85.7% of CL patients were workers who were job seekers
migrating from other parts of the country.34,35 People with certain
occupations may be exposed more than others to sand ﬂy bites
because they are outdoors during the time of sand ﬂy activity. Itwas observed that the risk of developing multiple lesions increased
1.5-fold in summer workers who work intermittently, especially as
construction workers, in some months of the year (seasonal jobs);
however, at the same time the risk of developing large-sized
lesions was decreased in these patients.
During the period of this study, from 2006 to 2011, the age
distribution of CL cases was relatively stable and about 50% of the
patients were in the 1–25 years age range; however, all age groups
were at risk of the disease. In known ZCL endemic regions of Iran,
the highest risk group in the studied populations is often children
aged less than 15 years. This was evidenced in Kerman Province
(<10 years of age, with a rate of 6.3%, and >50 years, the lowest
rate; study in 18 300 inhabitants aged 1–73 years),16 Fars Province
(10 years of age, with a rate of 70%; passive detection of any
patient with skin lesion),36 Shiraz (0–9 years of age, with a rate of
14.2%; age groups: <10 and 10 years),7 Mirjaveh (10 years of
age; in 3100 patients who were randomly selected and surveyed),6
Hormozgan Province (10–14 years of age; in 1392 patients, age
groups: 0–4, 5–9, 10–14, 15–19, 20–24, and >25 years),37 Ardakan
(10–14 years of age),5 Ardestan (10–14 years of age; age range: 1–
>55 years),38 Damghan (10–19 years; in 465 patients, age range:
1–88 years),31 and from part of Isfahan (most under 1 year of
age).39 Studies on CL associated with different age groups in
Afghanistan have shown that ACL is more commonly seen in the
younger age groups and that ZCL affects all age groups.21,28,40 In
Pakistan, in a study of 48 refugee camps (21 046 persons) and 19
neighboring villages (7305 persons) it was reported that younger
age increased the risk of ACL lesion and ACL scar development.41 In
a case–control study in South Anatolia, Turkey, risk factors for
outbreaks of CL due to Leishmania infantum were evaluated and it
was concluded that people aged from 5 to 19 years were the
highest risk group among the 282 persons studied.42 Although the
highest numbers of CL patients were aged under 25 years, the
likelihood of developing large-sized lesions was increased 2.5–3.5-
fold in patients aged 26 years. The effect of age might actually be
the effect of immune reactions on the skin lesion size. In
leishmaniasis it is known that the different outcomes of the
disease are a function of both the parasite and immune response of
the host.43–46
In this study, it was observed that most of the lesions appeared
on the extremities, hands and feet, and this pattern of lesion
development on the limbs is common in ZCL. It was reported that
45% of ZCL patients in Yazd,47 29.8% in Gonbad-e-Qabus,48 and 35%
in Orzoieh District16 developed lesions mostly on the hands. There
are studies that have indicated the development of CL lesions
mainly on the feet (65.3% in Hormozgan Province)37 and on the
face (50.4% in Fars Province, 47.0% in Kashan).15,36
Over a half of the CL patients in the present study had one skin
lesion. Likewise, most ZCL patients from other endemic regions of
the country have presented a single lesion, as reported from
Sabzevar (38.9%),30 Damghan (42.7%),26 Kermanshah (54.5%),32
Khatam (55%),47 and Bafgh (66.6%).49 In contrast, in Gonbad-e-
Qabus only 2.9% of the patients displayed one lesion and the
majority showed more than three lesions,48 similar to Orzoieh
District, Kerman Province, where 39% of CL patients had multiple
lesions.16 In ZCL due to L. major, multiple lesions might be seen;50
in the present study about 20% of CL patients had more than three
lesions. Sand ﬂies usually have a discontinuous blood-sucking
habit and may sting several times at every attack and cause the
development of several lesions on the skin.12 In one report from
Iraq, a total of 107 CL cases were diagnosed – 58% of them had
multiple lesions, while 42% had a single lesion.25 Patients with ACL
due to L. tropica usually present with one lesion.50
Standard antimonial treatments are chosen for every conﬁrmed
CL patient in accordance with the guidelines of the Ministry of
Health. Since most patients had a single lesion, usually on the hand
M. Nateghi Rostami et al. / International Journal of Infectious Diseases 17 (2013) e1198–e1206 e1205or foot, with mean size of 1.41  0.74 cm, the local intra-lesional
usage of Glucantime was the best choice of therapy, and resulted in a
good response.
The present study shows that CL due to L. major is endemic in
suburban areas of Qom Province. PCR revealed L. major to be the
causative agent, but in order to identify all epidemiological aspects
of ZCL, a study on the possible vectors and reservoirs of the disease
and their role in the transmission cycle is recommended. Since
leishmaniasis caused by L. major is typically zoonotic, control
measures should be focused on the rodents as the primary
reservoir hosts of ZCL, and on the Phlebotomus papatasi population
as the main vector of ZCL in Iran. P. papatasi is probably active
throughout the year and humans with active lesions may act as a
secondary reservoir, so the detection and treatment of patients
with active lesions should be considered. In the 2009 outbreak in
the region, different control measures were implemented by the
health system, including ﬁeld control of rodents and active case
ﬁnding, which seemed to reduce the increasing trend in CL
dissemination. Based on these data, awareness should be raised in
the high-risk populations comprising people with diabetes, young
adults (<25 years old), and those who work outdoors during the
summer. With regard to the treatment approach, the administra-
tion of Glucantime has been shown to be effective for most skin
lesions, however a combination with other treatment methods is
recommended for multiple/large CL lesions.
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